Takayasu arteritis in pregnancy — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Coordinate maternal, rheumatology and vascular teams and choose treatment according to gestational risk
Explanation lettering: E = shown as C · C = shown as D · D = shown as E
D is correct. Active large-vessel vasculitis in pregnancy requires multidisciplinary maternal and vascular care, pregnancy-compatible disease control and phenotype-specific treatment of hypertension or threatened organs. A permits maternal vascular injury and placental risk. B uses a contraindicated drug. C delays essential assessment. E ignores active inflammation, anatomy and maternal–fetal procedural risk.
Reference: BSR guideline on immunomodulatory anti-rheumatic drugs in pregnancy and breastfeeding: https://academic.oup.com/rheumatology/article/62/4/1370/6783014